Clinical Trial Update: By Pass Surgery With Stem Cell Therapy in Chronic Ischemic Cardiopathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bypass surgery with stem cell therapy for chronic ischemic heart disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease

Drugs mentioned

• Stem cell therapy (stem cell)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Ischemic Heart Disease | Phase 2 | Status: COMPLETED